Shire plc (LSE: SHP, NASDAQ: SHPG) announces today the launch of ADVATE (Octocog alfa – Recombinant Coagulation Factor VIII) in India for the treatment and prophylaxis of bleeding in patients with hemophilia A.
ADVATE Now Available in India for the Treatment and Prophylaxis of Hemophilia A
Shire plc (LSE: SHP, NASDAQ: SHPG) announces today the launch of ADVATE (Octocog alfa – Recombinant Coagulation Factor VIII) in India for the treatment and prophylaxis of bleeding in patients with hemophilia A.
Read more »